IMGT Co.,Ltd. (XKON:456570)
South Korea · Delayed Price · Currency is KRW 11,060
-230 (-2.04%)
At close: Aug 1, 2025
IMGT Co.,Ltd. Company Description
IMGT Co.,Ltd. engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems.
It develops IMGT-LPS, a technology that injects ultrasound-sensitive nanoparticles in the form of liposome-wrapped pharmacological substances into the body and releases drugs by irradiating ultrasound to the target area(tumor); IMGT-EMB, a nanoparticle for chemoembolization of liver cancer; IMGT-TSD, a targeted sonodynamic therapy that induces immune boosting mechanism by applying ultrasonic stimulation to the cancerous area; and IMGT-FUS, a device for non-invasive treatment.
The company was founded in 2010 and is based in Seongnam-si, South Korea.
IMGT Co.,Ltd.
| Country | South Korea |
| Founded | 2010 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Hakjong Lee |
Contact Details
Address: 408, Healthcare Innovation Park Seongnam-si, 13605 South Korea | |
| Phone | 82 3 1994 7077 |
| Website | nanoimgt.com |
Stock Details
| Ticker Symbol | 456570 |
| Exchange | Korea New Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Hakjong Lee | Chief Executive Officer |